Solvent abuse and the heart
The deliberate inhalation of volatile substances, usually halogenated or unsubstituted hydrocarbons, to obtain a-"high" is common among teenage boys and causes important morbidity and mortality' 2.80 deaths in Britain in 1983.3 Solvent abuse may cause both acute and chronic cardiotoxicity, and this issue carries three reports of serious cardiac problems associated with exposure to volatile hydrocarbons (pp 727 and 739).
In 1970 Bass reported an epidemic of sudden deaths associated with solvent sniffing in the United States.4 He proposed that these deaths were caused by an arrhythmia and suggested that volatile hydrocarbons might sensitise the heart to the arrhythmogenic effects of endogenous catecholamines. There is now much evidence to support this hypothesis. Firstly, solvent abuse has been followed by documented ventricular fibrillation.5-7 Secondly, sudden death related to solvent abuse has occurred often in circumstances associated with intense cardiac sympathetic stimulation-physical exertion, particularly running,48 and various forms of autoerotic behaviour."9 The case of myocardial infarction, possibly caused by coronary artery spasm, and ventricular fibrillation described by Cunningham et al (p 739) fits the same pattern. Thirdly, well controlled studies in dogs have shown that adrenaline given after many different inhaled volatile hydrocarbons may produce serious ventricular arrhythmias including ventricular fibrillation.'011 Furthermore, ventricular tachycardia has been seen in conscious dogs subjected to a loud noise or made to run on a treadmill after inhaling volatile hydrocarbons.' 12 Hypoxia,'0 hypokalaemia,'3 and alcohol'4 may all increase the risk of an arrhythmia after solvent abuse, and the cases described by McLeod et al (p 727) suggest that there may also be an adverse interaction with halothane.
Studies of acute toxicity have shown that inhaled volatile hydrocarbons can also induce bradyarrhythmias'516 and hypotension17; these observations were made, however, in animals under general anaesthesia and may not therefore be relevant to those who sniff glue or inhale from aerosol cans.
The relative toxicity of the many chemicals inhaled is not known, largely because we do not know the prevalence of abuse of each agent. Nevertheless, all of these substances may be cardiotoxic. Their effects on the heart are probably caused by non-specific physicochemical actions and seem to occur at doses similar to those that affect the central nervous system." This implies that any sniffer who obtains a "high" also runs the risk of developing an arrhythmia, particularly if he or she then exercises. Will general practitioners refer patients away from the local hospital and named consultant on to others who can see, diagnose, and treat more quickly? Can consultants be persuaded to send their patients on to colleagues within their specialty who can offer quicker treatment?
There is a practical difficulty. Despite modern communications, advances in technology, and the Korner reports on information systems in the NHS, there is no system within
